HC Wainwright & Co. Reiterates Buy on LB Pharmaceuticals, Maintains $45 Price Target

Benzinga · 2d ago
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates LB Pharmaceuticals (NASDAQ:LBRX) with a Buy and maintains $45 price target.